603193 Stock Overview
Engages in the research, production, and sale of mosquito repellent products, baby care products, and essential oil products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 603193 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Runben Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥23.80 |
| 52 Week High | CN¥27.62 |
| 52 Week Low | CN¥11.92 |
| Beta | 0 |
| 1 Month Change | -0.46% |
| 3 Month Change | 35.30% |
| 1 Year Change | 43.63% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 7.79% |
Recent News & Updates
Shareholder Returns
| 603193 | CN Personal Products | CN Market | |
|---|---|---|---|
| 7D | 0.4% | -1.3% | -2.6% |
| 1Y | 43.6% | -6.8% | 9.7% |
Return vs Industry: 603193 exceeded the CN Personal Products industry which returned -6.8% over the past year.
Return vs Market: 603193 exceeded the CN Market which returned 9.7% over the past year.
Price Volatility
| 603193 volatility | |
|---|---|
| 603193 Average Weekly Movement | 9.5% |
| Personal Products Industry Average Movement | 7.9% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 603193 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603193's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 917 | n/a | www.runben.com |
Runben Biotechnology Co., Ltd. engages in the research, production, and sale of mosquito repellent products, baby care products, and essential oil products. The company sells its products through online channels. Runben Biotechnology Co., Ltd.
Runben Biotechnology Co., Ltd. Fundamentals Summary
| 603193 fundamental statistics | |
|---|---|
| Market cap | CN¥9.63b |
| Earnings (TTM) | CN¥306.18m |
| Revenue (TTM) | CN¥1.25b |
31.5x
P/E Ratio7.7x
P/S RatioIs 603193 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603193 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.25b |
| Cost of Revenue | CN¥524.22m |
| Gross Profit | CN¥722.73m |
| Other Expenses | CN¥416.55m |
| Earnings | CN¥306.18m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.76 |
| Gross Margin | 57.96% |
| Net Profit Margin | 24.55% |
| Debt/Equity Ratio | 0% |
How did 603193 perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield46%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 19:10 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Runben Biotechnology Co., Ltd. is covered by 12 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xiyue Zhang | Chasing Securities |
| Junhao Fan | China International Capital Corporation Limited |
| Zhuonan Xu | China International Capital Corporation Limited |